Pablo Corral: Key Take‑Home Messages on Familial Hypercholesterolemia
Pablo Corral, Pharmacology Professor at FASTA University, Past President of Argentine Lipid Society, shared a post on LinkedIn about a recent article by Zahid Ahmad et al. published in Journal of Clinical Lipidology, adding:
“Update on familial hypercholesterolemia: An expert clinical consensus from the National Lipid Association
- FH is common (approx.1:311) and systematically underdiagnosed therefore the real problem is not rarity, it is detection
- Driven by lifelong LDL-C exposure, not a single value therefore risk equals LDL-C multiplied by time
- Genetics help, but phenotype rules therefore treat based on LDL-C burden, not just mutations
Diagnosis
- LDL-C ≥190 mg/dL (adults) indicates FH, but confirm clinically
- Genetic testing: useful for cascade screening, not mandatory
- Always exclude secondary causes before labeling
Screening
- Universal pediatric screening (9–11 yrs) is not optional- it’s delayed prevention
- Cascade screening represents the highest yield strategy (and still underused)
Risk
Standard risk calculators?
Useless in FH consequently they underestimate risk
Risk depends on:
- Lifetime LDL exposure
- Lp(a)
- Family history
- Timing of treatment
Treatment (no shortcuts)
Lifelong, early, aggressive
Targets:
- less than 55 mg/dL (secondary prevention)
- less than 70 mg/dL (primary prevention)
Start with:
- High-intensity statin, ezetimibe, PCSK9i / others as needed
- More than or equal to 50% LDL reduction is the floor, not the goal
Take-home
- FH is not a lipid disorder.
- It’s a time-dependent vascular disease.
- Diagnose early, treat hard, treat forever.”
Title: Update on familial hypercholesterolemia: An expert clinical consensus from the National Lipid Association
Authors: Zahid Ahmad, Anandita Agarwala, Marina Cuchel, P. Barton Duell, Robert A. Hegele, Lisa Hudgins, Allison Jamison, Dinesh Kalra, Amit Khera, Joshua W. Knowles, Iftikhar J. Kullo, Ana Morales, Mark A. Rothstein, Joseph J. Saseen, Daniel E. Soffer, Bruce A. Warden, William S. Weintraub, Lauren Williams, Anne C. Goldberg
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 23, 2026, 03:17Wolfgang Miesbach: The Haemophilia A Gene Therapy Story Is Moving from West to China
-
Apr 23, 2026, 02:17Francisco Chacón-Lozsán: Pulmonary Artery Catheter in Cardiogenic Shock From Obsolete Device to Modern Decision Tool
-
Apr 23, 2026, 01:33Maha Othman: Our Research Group Had a Highly Successful Showing at the ISLH 2026 Congress
-
Apr 22, 2026, 17:19Ralf Ludwig: Bridging Population Data and Immunology in Inflammatory Diseases
-
Apr 22, 2026, 17:15Giacomo Rossi: Genetic Study Reveals 10 Genes in Hyperemesis Gravidarum
-
Apr 22, 2026, 17:06Maura Boerio: Quantifying Barriers to Care in Vascular Ehlers-Danlos Syndrome
-
Apr 22, 2026, 17:05Kausik Ray։ Metabolically Healthy Obesity Is Being Re-Evaluated as a High-Risk Condition Needing Closer Attention
-
Apr 22, 2026, 16:58Baba-Jallah Epega: Sickle Cell Resilience Through Patient Voices and Clinical Insight
-
Apr 22, 2026, 16:44Francisco Chacón-Lozsán: Cytokine Storm Is Not Just Inflammation, It Is Organ Failure in Motion